Clinical Trial Update: A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia [Phase 1]

View source ↗

Summary

This clinical trial update notes the termination of a Phase 1 study of ONO-7746 in adult cancer patients with chemotherapy-induced thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• ONO-7746

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Chemotherapy-Induced Thrombocytopenia | Phase 1 | Status: TERMINATED